Figure 1.
The mean serum levels of (a) IL-12 and TNF-α and (b) IL-10 and IFN-γ in APTB patients (n = 20). Naïve: patients who had not received ATT. 2T: patients who received ATT for two months. 4T: patients who received ATT for four months. 6T: patients who received ATT for six months. aSignificantly different compared with 4T (P = .034 for TNF-α, P = .018 for IL-10) and 6T (P = .004 for TNF-α, P = .000 for IL-10) patients. bSignificantly different compared with 2T (P = .008), 4T (P = .000), and 6T (P = .001).